Literature DB >> 24377111

Digoxin significantly improves all-cause mortality in atrial fibrillation patients with severely reduced left ventricular systolic function.

Nileshkumar J Patel, Michael Hoosien, Abhishek Deshmukh, Apurva O Badheka, Peeyush M Grover, Neeraj Shah, Vikas Singh, Kathan Mehta, Ankit Chothani, Ghanshyambhai T Savani, Shilpkumar Arora, Vipulkumar Bhalara, Nilay Patel, Dhaval Khalpada, Ankit Rathod, Thomas J Vazzana, James Lafferty, Juan F Viles-Gonzalez, Raul D Mitrani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24377111     DOI： 10.1016/j.ijcard.2013.10.040

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  8 in total

1.  Beta-blockers or Digoxin for Atrial Fibrillation and Heart Failure?

Authors:  Laurent Fauchier; Guillaume Laborie; Nicolas Clementy; Dominique Babuty
Journal:  Card Fail Rev       Date:  2016-05

2.  Association of digitalis treatment with outcomes following myocardial infarction in patients with heart failure or evidence of left ventricular dysfunction: an analysis from the High-Risk Myocardial Infarction Database Initiative.

Authors:  Stefano Coiro; Nicolas Girerd; Patrick Rossignol; Johann Bauersachs; Bertram Pitt; Renaud Fay; Giuseppe Ambrosio; Scott D Solomon; Kenneth Dickstein; Faiez Zannad
Journal:  Clin Res Cardiol       Date:  2017-04-28       Impact factor: 5.460

3.  Assumption versus evidence: the case of digoxin in atrial fibrillation and heart failure.

Authors:  Udo Bavendiek; Lukas Aguirre Davila; Armin Koch; Johann Bauersachs
Journal:  Eur Heart J       Date:  2017-07-14       Impact factor: 29.983

4.  Digoxin-mortality: randomized vs. observational comparison in the DIG trial.

Authors:  Lukas Aguirre Dávila; Kristina Weber; Udo Bavendiek; Johann Bauersachs; Janet Wittes; Salim Yusuf; Armin Koch
Journal:  Eur Heart J       Date:  2019-10-21       Impact factor: 29.983

5.  Digoxin Impact on Heart Failure Patients with Atrial Fibrillation.

Authors:  Andreas Gerakaris; Francesk Mulita; Ioanna Koniari; Eleni Artopoulou; Virginia Mplani; Grigorios Tsigkas; Mohammed Abo-Elseoud; Nicholas Kounis; Dimitrios Velissaris
Journal:  Med Arch       Date:  2022-02

Review 6.  Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data.

Authors:  Oliver J Ziff; Deirdre A Lane; Monica Samra; Michael Griffith; Paulus Kirchhof; Gregory Y H Lip; Richard P Steeds; Jonathan Townend; Dipak Kotecha
Journal:  BMJ       Date:  2015-08-30

7.  Increased All-Cause Mortality Associated With Digoxin Therapy in Patients With Atrial Fibrillation: An Updated Meta-Analysis.

Authors:  Ying Chen; Xiaoyan Cai; Weijun Huang; Yanxian Wu; Yuli Huang; Yunzhao Hu
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

8.  Beta-blocker treatment in heart failure patients with atrial fibrillation: challenges and perspectives.

Authors:  Emmanouil Chourdakis; Ioanna Koniari; Dimitrios Velissaris; Grigorios Tsigkas; Nikolaos G Kounis; Neriman Osman
Journal:  J Geriatr Cardiol       Date:  2021-05-28       Impact factor: 3.327
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.